Mark S. Gelder Md.
SVP & Chief Medical Officer, HERON THERAPEUTICS, INC. /DE/.
Companies
- Traws Pharma, Inc.Chief Medical Officer Jun 17, 2021 to Mar 14, 20231
- HERON THERAPEUTICS, INC. /DE/SVP & Chief Medical Officer Dec 13, 2012 to Dec 15, 20142
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Traws Pharma, Inc. TRAW10,487 shares3$4.0K at $0.38Feb 7, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 7, 2023Shares withheld for tax 1,242 shares at $1.36 of Traws Pharma, Inc.3
- Feb 7, 2023Exercised options 5,833 shares of Traws Pharma, Inc.3
- Aug 3, 2022Shares withheld for tax 1,135 shares at $1.32 of Traws Pharma, Inc.4
- Aug 2, 2022Exercised options 4,650 shares of Traws Pharma, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Aug 4, 2022